Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 01, 2022

BUY
$1.81 - $2.76 $73,408 - $111,937
40,557 New
40,557 $78,000
Q2 2021

Aug 11, 2021

BUY
$7.54 - $9.79 $26,774 - $34,764
3,551 New
3,551 $28,000
Q4 2017

Feb 09, 2018

SELL
$4.32 - $5.52 $19,440 - $24,839
-4,500 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$4.35 - $5.25 $19,575 - $23,625
4,500
4,500 $23,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.